Related Experiment Videos
Susceptibility of Canadida albicans to miconazole
Antimicrobial Agents and Chemotherapy
|June 1, 1978
Abstract:
A total of 439 clinical isolates of Candida albicans were tested for susceptibility to miconazole by the agar dilution technique. When tests were read at 48 and 24 h, 56 and 84%, respectively, of the strains were completely inhibited by 4.0 mug of miconazole per ml, the estimated upper limit of probable clinical susceptibility.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Neutron imaging of the deuterium-tritium tamping gas volume in an inertial confinement fusion hohlraum.
The Review of scientific instruments·2024
Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016.
Journal of internal medicine·2020
Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016.
Journal of internal medicine·2020
Decreased tibial nerve movement in patients with failed back surgery syndrome and persistent leg pain.
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2019
The 2014 Survey on Living with Chronic Diseases in Canada on Mood and Anxiety Disorders: a methodological overview.
Health promotion and chronic disease prevention in Canada : research, policy and practice·2016
Fortuitous detection of campylobacter bacteremia.
Saudi medical journal·2016
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients.
Antimicrobial agents and chemotherapy·2026
XAB06, a glyco-humanized broad-spectrum anti-Pseudomonas aeruginosa polyclonal antibody, protects mice in a lethal sepsis model.
Antimicrobial agents and chemotherapy·2026
In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States.
Antimicrobial agents and chemotherapy·2026
Impact of renal impairment on pharmacokinetics, safety, and tolerability of funobactam, combined with imipenem and cilastatin.
Antimicrobial agents and chemotherapy·2026
Next-generation anti-infective drugs in the post-antibiotic era: focusing on anti-virulence agents targeting the bacterial quorum sensing system.
Frontiers in cellular and infection microbiology·2026
[Topical Therapy of Otitis Externa: Potential Use of Combined Preparations].
Vestnik otorinolaringologii·2026